227 related articles for article (PubMed ID: 15805796)
1. Circulating angiogenic factors in preeclampsia.
Levine RJ; Karumanchi SA
Clin Obstet Gynecol; 2005 Jun; 48(2):372-86. PubMed ID: 15805796
[No Abstract] [Full Text] [Related]
2. Molecular mechanisms of preeclampsia.
Mutter WP; Karumanchi SA
Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
[TBL] [Abstract][Full Text] [Related]
3. A possible placental factor for preeclampsia: sFlt-1.
Kita N; Mitsushita J
Curr Med Chem; 2008; 15(7):711-5. PubMed ID: 18336285
[TBL] [Abstract][Full Text] [Related]
4. Preeclampsia: new insights.
Shah DM
Curr Opin Nephrol Hypertens; 2007 May; 16(3):213-20. PubMed ID: 17420664
[TBL] [Abstract][Full Text] [Related]
5. The vascular endothelial growth factor family in adverse pregnancy outcomes.
Andraweera PH; Dekker GA; Roberts CT
Hum Reprod Update; 2012 Jul; 18(4):436-57. PubMed ID: 22495259
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy.
Karumanchi SA
Hypertension; 2016 Jun; 67(6):1072-9. PubMed ID: 27067718
[No Abstract] [Full Text] [Related]
7. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
8. Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia.
Furuya M; Kurasawa K; Nagahama K; Kawachi K; Nozawa A; Takahashi T; Aoki I
J Pregnancy; 2011; 2011():123717. PubMed ID: 21490787
[TBL] [Abstract][Full Text] [Related]
9. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia.
Seki H
Acta Obstet Gynecol Scand; 2014 Oct; 93(10):959-64. PubMed ID: 25139038
[TBL] [Abstract][Full Text] [Related]
10. [The role of angiogenic factors in preeclampsia].
Alasztics B; Gullai N; Molvarec A; Rigó J
Orv Hetil; 2014 Nov; 155(47):1860-6. PubMed ID: 25403279
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.
Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669
[TBL] [Abstract][Full Text] [Related]
12. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
[TBL] [Abstract][Full Text] [Related]
13. Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patrício B; Quintanilha A; Santos-Silva A
Growth Factors; 2009 Dec; 27(6):345-51. PubMed ID: 19919522
[TBL] [Abstract][Full Text] [Related]
14. Redefining preeclampsia using placenta-derived biomarkers.
Staff AC; Benton SJ; von Dadelszen P; Roberts JM; Taylor RN; Powers RW; Charnock-Jones DS; Redman CW
Hypertension; 2013 May; 61(5):932-42. PubMed ID: 23460278
[No Abstract] [Full Text] [Related]
15. Angiogenic factors in preeclampsia: so complex, so simple?
Berkane N; Lefevre G; Hertig A
Nephrol Dial Transplant; 2007 Oct; 22(10):2753-6. PubMed ID: 17617654
[No Abstract] [Full Text] [Related]
16. Approaching the threshold for predicting preeclampsia: monitoring angiogenic balance during pregnancy.
Banek CT; Gilbert JS
Hypertension; 2011 Nov; 58(5):774-5. PubMed ID: 21947465
[No Abstract] [Full Text] [Related]
17. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
[TBL] [Abstract][Full Text] [Related]
18. The SK3 channel promotes placental vascularization by enhancing secretion of angiogenic factors.
Rada CC; Murray G; England SK
Am J Physiol Endocrinol Metab; 2014 Nov; 307(10):E935-43. PubMed ID: 25249506
[TBL] [Abstract][Full Text] [Related]
19. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiogenic factors and preeclampsia.
Tsatsaris V; Goffin F; Foidart JM
N Engl J Med; 2004 May; 350(19):2003-4; author reply 2003-4. PubMed ID: 15128904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
